Table 1.
Characteristics of studies in this systematic review and meta‐analysis.
| Study | Design | N | TG TURBT + TURP, n | CG TURBT, n | TG total recurr., n | CG total recurr., n | TG BN/PU recur., n | CG BN/PU recur., n | TG progress., n | CG progress., n | TG mean FU, months | CG mean FU, months |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wang et al. (2020) [16] | Retro. | 236 | 118 | 118 | 32 | 38 | 11 | 8 | 9 | 11 | 20.2 | 18.9 |
| Dellabella et al. (2018) [9] | RCT | 85 | 42 | 43 | 22 | 27 | 8 | 9 | NA | NA | 36.91 | 35.16 |
| Li et al. (2014) [10] | RCT | 62 | 25 | 37 | 4 | 7 | 1 | 3 | 1 | 2 | ≥12 | ≥12 |
| Jaidane et al. (2010) [5] | Retro. | 170 | 85 | 85 | 17 | 20 | 1 | 1 | 2 | 2 | 35.2 | 33.1 |
| Singh et al. (2009) [11] | RCT | 48 | 24 | 24 | 12 | 11 | 4 | 3 | 3 | 2 | 35.71 | 37.55 |
| Ham et al. (2009) [3] | Retro. | 203 | 107 | 106 | 31 | 46 | 0 | 0 | 10 | 12 | 48 | 45 |
| Park et al. (2009) [17] | Retro. | 189 | 24 | 165 | 9 | 37 | 1 | 3 | 2 | 10 | 52.2 | 43.8 |
| Ugurlu et al. (2007) [12] | Retro. | 65 | 31 | 34 | 11 | 14 | 1 | 1 | 3 | 3 | 30.6 | 27.4 |
| Tsivian et al. (2003)* [4] | Retro. | 51 | 51 | NA | 35 | NA | 11 | NA | 3 | NA | 37.3 | NA |
| Vicente et al. (1988) [13] | Retro. | 200 | 100 | 100 | 55 | 73 | 10 | 10 | NA | NA | 47 | 46 |
| Laor et al. (1981) [14] | Retro. | 287 | 137 | 150 | 77 | 92 | 21 | 27 | NA | NA | 69 | 96 |
| Greene et al. (1972) [15] | Retro. | 200 | 100 | 100 | 54 | 54 | 17 | 16 | NA | NA | 132 | 132 |
*
This study was designed without a control group. CG, control group; FU, follow‐up; NA, not available; progress., progression; recurr., recurrence; Retro., retrospective; TG, treatment group.